TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

被引：39
|
作者：
Zixin, Ye [1 ,2 ,3 ,4 ]
Lulu, Chen [5 ,6 ]
Xiangchang, Zeng [1 ,2 ,3 ,4 ]
Qing, Fang [5 ]
Binjie, Zheng [1 ,2 ,3 ,4 ]
Chunyang, Luo [6 ]
Tai, Rao [1 ,2 ,3 ,4 ]
Dongsheng, Ouyang [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Peoples R China
[2] Cent South Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha, Peoples R China
[3] Minist Educ, Engn Res Ctr Appl Technol Pharmacogen, Changsha, Peoples R China
[4] Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[5] Hunan Key Lab Bioanal Complex Matrix Samples, Changsha, Peoples R China
[6] Affiliated Hosp Xiangnan Univ, Dept Clin Pharm, Chenzhou, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷
关键词：
trimethylamine N-oxide; chronic kidney disease; gut microbiota; targeted TMAO drugs; mechanism; treatment; TRIMETHYLAMINE-N-OXIDE; FLAVIN-CONTAINING MONOOXYGENASE; L-CARNITINE; RENAL-INSUFFICIENCY; PROBIOTIC SUPPLEMENTATION; MICROBIAL-METABOLISM; SECONDARY PREVENTION; CONTRIBUTES; PROGRESSION; FMO3;
D O I：
10.3389/fphar.2022.929262
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The gut microbiota and its metabolites have become a hotspot of recent research. Trimethylamine N-oxide (TMAO) metabolized by the gut microbiota is closely related to many diseases such as cardiovascular disease, chronic kidney disease, type 2 diabetes, etc. Chronic kidney disease (CKD) is an important contributor to morbidity and mortality from non-communicable diseases. Recently, increasing focus has been put on the role of TMAO in the development and progress of chronic kidney disease. The level of TMAO in patients with chronic kidney disease is significantly increased, and a high level of TMAO deteriorates chronic kidney disease. This article describes the relationship between TMAO and chronic kidney disease and the research progress of drugs targeted TMAO, providing a reference for the development of anti-chronic kidney disease drugs targeted TMAO.
引用
收藏
页数：12
相关论文
共 50 条
  • [31] Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?
    Cavalcanti Neto, Marinaldo Pacifico
    Aquino, Jailane de Souza
    Romao da Silva, Larissa de Fatima
    Silva, Ruanniere de Oliveira
    de Lima Guimaraes, Keyth Sulamitta
    de Oliveira, Yohanna
    de Souza, Evandro Leite
    Magnani, Marciane
    Vidal, Hubert
    de Brito Alves, Jose Luiz
    PHARMACOLOGICAL RESEARCH, 2018, 130 : 152 - 163
  • [32] Nox4 as a potential therapeutic target for treatment of uremic toxicity associated to chronic kidney disease
    Gorin, Yves
    KIDNEY INTERNATIONAL, 2013, 83 (04) : 541 - 543
  • [33] Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease
    Hu, Peng
    Hu, Bo
    Wang, Jing
    Lu, Ling
    Qin, Yuan Han
    MEDICAL SCIENCE MONITOR, 2011, 17 (06): : HY14 - HY20
  • [34] Vascular dysfunction in Alzheimer's disease: a biomarker of disease progression and a potential therapeutic target
    Karan Govindpani
    Chitra Vinnakota
    Henry J.waldvogel
    Richard L.Faull
    Andrea Kwakowsky
    Neural Regeneration Research, 2020, (06) : 1030 - 1032
  • [35] Vascular dysfunction in Alzheimer's disease: a biomarker of disease progression and a potential therapeutic target
    Govindpani, Karan
    Vinnakota, Chitra
    Waldvogel, Henry J.
    Faull, Richard L.
    Kwakowsky, Andrea
    NEURAL REGENERATION RESEARCH, 2020, 15 (06) : 1030 - 1032
  • [36] PRKCD as a potential therapeutic target for chronic obstructive pulmonary disease
    Li, Siqi
    Huang, Qiong
    Zhou, Dongbo
    He, Baimei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [37] DPP4, a potential tumor biomarker, and tumor therapeutic target: review
    Sun, Lu
    Ma, Yuhui
    Geng, Chenchen
    Gao, Xiaoqian
    Li, Xinbing
    Ru, Qi
    Zhu, Shuzhen
    Zhang, Ping
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [38] NCDN is a Potential Biomarker and Therapeutic Target for Glioblastoma
    Huang, Xiaokai
    Xu, Chengwu
    Dai, Haipeng
    Yang, Jianchun
    Huang, Tingting
    Chen, Shuan
    Qi, Lingxin
    Ruan, Jichen
    Wang, Juxiang
    JOURNAL OF CANCER, 2024, 15 (04): : 1067 - 1076
  • [39] LncRNA as potential biomarker and therapeutic target in glioma
    Xun Xu
    Yuan Liang
    Ilgiz Gareev
    Yanchao Liang
    Rui Liu
    Ning Wang
    Guang Yang
    Molecular Biology Reports, 2023, 50 : 841 - 851
  • [40] HDL as a Biomarker, Potential Therapeutic Target, and Therapy
    Navab, Mohamad
    Anantharamaiah, G. M.
    Reddy, Srinivasa T.
    Van Lenten, Brian J.
    Al Fogelman, Alan
    DIABETES, 2009, 58 (12) : 2711 - 2717
12345